All In Biotech

Drug Trial Radar · NCT07625384

Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease

International Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Study of the Efficacy and Safety of Goflikicept and Olokizumab as the Second-line Therapy in Patients With Still's Disease

Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

52

Planned (sponsor's estimate)

Start

May 18, 2026

Primary completion

Dec 14, 2027

Study completion Jul 1, 2028

Sponsor

Lead sponsor
R-Pharm International, LLCIndustry
Sponsor type
Industry
First posted
Jun 4, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to evaluate the efficacy and safety of goflikicept (GFC) and olokizumab (OKZ) in patients with Still's disease

Conditions

  • Still Disease

Interventions

  • PlaceboDrug

    0.9% Sodium Chloride solution for Injection

  • GoflikiceptBiological

    solution for subcutaneous injection and intravenous infusion, 40 mg/mL

  • OlokizumabBiological

    solution for subcutaneous injection and intravenous infusion, 160 mg/mL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients who achieved and maintained low disease activity or remission according to DAVID criteria at Day 7 (excluding the arthritis criterion) and achieved DAVID remission criteria at Day 28Time frame: Day 7 (low disease activity or remission) and Day 28 (remission)

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Republic Clinical and Diagnostic Center of the Ministry of Health of the Udmurt Republic

    Izhevsk, Russia

  • "Vashe Zdorovie" Research Medical Complex, LLC

    Kazan', Russia

  • Family Clinic No. 4, LLC

    Korolyov, Russia

  • Limited Liability Company "OLLA-MED"

    Moscow, Russia

  • State Budgetary Healthcare Institution "A.S. Loginov Moscow Clinical Scientific Center of the Moscow Department of Healthcare"

    Moscow, Russia

  • V.A. Nasonova Research Institute of Rheumatology (Federal State Budgetary Scientific Institution)

    Moscow, Russia

  • Limited Liability Company "Firm ORIS"

    Moscow, Russia

  • State Budgetary Healthcare Institution of the City of Moscow "N.I. Pirogov City Clinical Hospital No. 1 of the Moscow Department of Healthcare"

    Moscow, Russia

  • I.M. Sechenov First Moscow State Medical University, University Clinical Hospital No. 3, E.M. Tareev Clinic of Rheumatology, Nephrology and Occupational Pathology

    Moscow, Russia

  • Russian Gerontology Clinical Research Center (RGNC) of Pirogov Russian National Research Medical University

    Moscow, Russia

  • "Zdorovaya Semya" Medical Center

    Novosibirsk, Russia

  • Federal Research Center "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences"

    Novosibirsk, Russia

  • Budgetary Healthcare Institution of the Omsk Region "Regional Clinical Hospital"

    Omsk, Russia

  • State Budgetary Healthcare Institution "Orenburg Regional Clinical Hospital named after V.I. Voynov"

    Orenburg, Russia

  • State Budgetary Healthcare Institution "V.A. Baranov Republican Hospital"

    Petrozavodsk, Russia

  • Limited Liability Company "Medical Technologies"

    Saint Petersburg, Russia

  • Interleukin LLC

    Saint Petersburg, Russia

  • State Budgetary Healthcare Institution "Leningrad Regional Clinical Hospital"

    Saint Petersburg, Russia

  • Limited Liability Company "Medical-Sanitary Unit No. 157" (MSU No. 157)

    Saint Petersburg, Russia

  • State Healthcare Institution "Regional Clinical Hospital" of Saratov

    Saratov, Russia

  • Smolensk Regional Rheumatology Center at the "RZD-Medicine" Clinical Hospital (Private Healthcare Institution)

    Smolensk, Russia

  • Siberian State Medical University (Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of the Russian Federation)

    Tomsk, Russia

  • State Budgetary Healthcare Institution "G.G. Kuvatov Republican Clinical Hospital"

    Ufa, Russia

  • State Healthcare Institution "City Clinical Emergency Hospital No. 25"

    Volgograd, Russia

  • Yaroslavl State Medical University (Federal State Budgetary Educational Institution of Higher Education of the Ministry of Health of the Russian Federation)

    Yaroslavl, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.